TNFSF10 and systemic sclerosis: Interestingly, we validated that expression of endogenous TRAIL was increased in skin tissues collected from patients with SSc and morphea, further supporting several sets of data that have shown elevated levels of circulating TRAIL in scleroderma patients36.